New research estimates 24% of cancers in men that were detected in 2012 were overdiagnosed, meaning they never would have caused harm if left untreated.
Academic rigor, journalistic flair
Articles on PSA test
Displaying all articles
Men with faults in their BRCA2 gene are at higher risk of aggressive prostate cancer.
Since the 1980s, PSA tests have been used for the diagnosis and follow-up of prostate cancer. However, its use as a screening test for prostate cancer remains controversial.
A family physician and public health researcher explains why he isn’t getting a prostate cancer test in Movember or at any time in the near future.
Top contributors
-
Professor of Public Health, University of Sydney
-
Professor of Medicine, Bond University
-
Associate Professor in Clinical Epidemiology, Sydney School of Public Health, University of Sydney
-
Professor of Surgery, Eastern Health Clinical School, Monash University
-
Professor of Family Medicine, University of Calgary
-
Lecturer in Medicine and Molecular Genetics, University of Central Lancashire
-
Associate Professor, Biostatistician, Institute for Evidence-Based Healthcare, Bond University
-
Senior Lecturer, School of Medicine, Griffith University
